Utah preferred prescription drug list savings less than projected

NewsGuard 100/100 Score

Utah's Medicaid preferred prescription drug list in its first year has reduced spending by nearly $546,000, but the savings fell about $2.75 million short of original estimates by the Utah Department of Health, according to Michael Hales, the director of the state Division of Health Care Financing, the Salt Lake Tribune reports.

According to health department Director David Sundwall, the full savings of the program was not achieved in part because of changes to legislation that created the preferred drug list. The Tribune reports that state lawmakers were concerned Medicaid costs could increase if beneficiaries had complications or reactions with preferred drugs, and they approved an amendment to the bill that allows physicians to write "dispense as written" on prescriptions, rather than requiring prior authorization.

In addition, Hales said that the full savings projections were not met this fiscal year because drugs were added to the list over several months. He said that in 2009 all drug classes will be included on the list and administrative costs will be lower, which could reduce Medicaid spending by nearly $1.2 million. Sundwall said he intends to ask lawmakers to reinstate the prior authorization requirement for physicians to prescribe drugs that are not on the preferred list. In addition, the state health department currently is working with the Utah Medical Association to approach physicians who most frequently prescribe drugs not on the list. The health department also will request that the state Legislature redefine "psychotropic" so additional drug classes can be placed on the list (Rosetta, Salt Lake Tribune, 9/18).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Special drug-pricing program boosts prostate cancer treatment adherence